Opinion · Supreme Court of the United States

Dr. Miles Medical Co. v. John D. Park & Sons Co.

Dr. Miles Med. Co. v. John D. Park & Sons Co., 220 U.S. 373 (1911)

Type
Opinion
Court
Supreme Court of the United States
Jurisdiction
Federal
Date
1911-04-10
Topic
general

How later courts describe this case

  • holding vertical price fixing is a violation of § 1
  • "With respect to contracts in restraint of trade, the earlier doctrine of the common law has been substantially modified in adaptation to modern conditions"
  • "Nor can the manufacturer by rule and notice, in the absence of contract or statutory right, even though the restriction be known to purchasers, fix prices for future sales."
  • seminal decision antedating per se doctrine and declaring minimum resale price maintenance contracts unlawful
  • per se rule No. 05-5062 Expert Masonry, Inc. v. Boone County, Page 7 Kentucky, Fiscal Court, et al. against concerted vertical action to set prices through distribution
  • per se rule against concerted vertical action to set prices through distribution
  • "I think that at least it is safe to say that the most enlightened judicial policy is to let people manage their own business in their own way, unless the ground for interference is very clear.”
  • which finds resale price fixing to be per se unlawful

Citator

Dr. Miles Medical Co. v. John D. Park & Sons Co. is no longer good law, at least in part: overruled by Leegin Creative Leather Products, Inc. v. PSKS, Inc. (2007). 612 later decisions cite it, 2 of them negatively.

Authority status
negative
Cited by
612 opinions
Negative treatment
2 citing opinions

Headnotes

  1. Torts — Tortious Interference An actionable wrong is committed by one who maliciously interferes with a contract between two parties and induces one of them to break the contract to the injury of the other, and in the absence of an adequate remedy at law equitable relief will be granted; but plaintiffs are not entitled to such relief where the contract under which they claim is itself invalid. 220 U.S. 373, 404-405
  2. Antitrust & Competition Law — Resale Price Maintenance A system of contracts between a manufacturer and its wholesale and retail dealers by which the manufacturer attempts to control not merely the prices at which its agents may sell its products, but the prices for all sales by all dealers at wholesale or retail, whether purchasers or subpurchasers, thereby eliminating all competition and fixing the amount which the consumer shall pay, amounts to restraint of trade and is invalid both at common law and, so far as it affects interstate commerce, under the Sherman Anti-trust Act of July 2, 1890. 220 U.S. at 408-409
  3. Antitrust & Competition Law — Restraint of Trade Agreements restricting resale prices are not excepted from the general rule against restraints of trade, and rendered valid, merely because they relate to proprietary medicines manufactured under a secret process rather than under letters patent; a manufacturer is not entitled to control prices on all sales of his own products in restraint of trade. 220 U.S. at 400-401
  4. Patent Law — Rights of Patentee The rights enjoyed by a patentee are derived from statutory grant under authority conferred by the Constitution and are the reward received in exchange for advantages derived by the public once the period of protection has expired; the rights of one who does not disclose his secret process so as to secure a patent lie outside the policy of the patent laws and must be determined by the legal principles applicable to ownership of such process. 220 U.S. at 401-402
  5. Trade Secrets Law — Ownership of Process Protection of an unpatented process of manufacture does not necessarily extend to the sale of articles manufactured under that process, and the secret process itself is not communicated by the sale of the manufactured article. 220 U.S. at 402-403
  6. Antitrust & Competition Law — Proprietary Medicines — Equal Treatment A manufacturer of unpatented proprietary medicines stands on the same footing as to the right to control the sale of his product as the manufacturers of other articles, and the fact that the article may have curative properties does not justify restrictions that would be unlawful as to articles designed for other purposes. 220 U.S. at 404
  7. Contracts Law — Restraint of Trade — Price Fixing by Notice A manufacturer of unpatented articles cannot, by rule or notice, in the absence of statutory or contractual right, fix prices for future sales, even though the restriction is known to purchasers; whatever rights the manufacturer may have in that respect must arise by agreements that are lawful. 220 U.S. at 405
  8. Contracts Law — Restraint of Trade — Reasonableness Although the earlier common-law doctrine regarding restraint of trade has been substantially modified, the public interest remains the first consideration; to sustain a restraint it must be reasonable both as to the public and as to the parties and limited to what is reasonably necessary under the circumstances for the protection of the covenantee, and otherwise restraints are void as against public policy. 220 U.S. at 406
  9. Antitrust & Competition Law — Combinations Fixing Prices Agreements or combinations between dealers having for their sole purpose the destruction of competition and the fixing of prices are injurious to the public interest and void, and are not saved by the advantages which the participants expect to derive from the enhanced price to the consumer. 220 U.S. at 408
  10. Antitrust & Competition Law — Control of Goods After Sale Where commodities have passed into the channels of trade and are owned by dealers, the validity of agreements to prevent competition and maintain prices is not determined by whether the commodities were produced by one manufacturer or by several, or whether they were previously owned by one or by many; the public is entitled to whatever advantage may be derived from competition in the subsequent traffic. 220 U.S. at 409